Stockscreener 앱 받기
207.37
2.86%
-5.98
Resmed Inc 주식(RMD)의 최신 뉴스
ResMed director Peter Farrell sells $439,480 in stock - Investing.com India
RMD Stock Benefits From the Launch of NightOwl Across US - TradingView
Should I buy Fisher & Paykel or ResMed shares? - The Motley Fool Australia
ResMed Inc Reports Changes in CDI and Securities Issuance - TipRanks
ResMed Inc’s General Counsel Reports Stock Transaction - TipRanks
ResMed launches at-home sleep apnea test - MassDevice
ResMed’s global general counsel sells $14,263 in stock - Investing.com India
ResMed (NYSE:RMD) Launches NightOwl Device to Simplify Home Sleep Apnea Testing Across US - Yahoo Finance
ResMed’s global general counsel sells $14,263 in stock By Investing.com - Investing.com South Africa
Investing in ResMed (NYSE:RMD) five years ago would have delivered you a 50% gain - simplywall.st
Resmed Launches NightOwl Home Sleep Apnea Test - Medical Product Outsourcing
ResMed Inc. (RMD): A Bull Case Theory - Insider Monkey
Game-Changing Sleep Apnea Test: Resmed's Tiny Device Tackles 80% Diagnosis Gap - Stock Titan
Resmed To Report Third Quarter Fiscal 2025 Earnings On April 23, 2025 - MarketScreener
ResMed Director Announces Sale of Common Shares - TipRanks
Resmed to Announce Q3 Fiscal 2025 Earnings - TipRanks
Resmed Inc. (RMD): Jim Cramer Says He Likes This Sleep Apnea Treatment Stock - Yahoo Finance
Resmed to Report Third Quarter Fiscal 2025 Earnings on April 23, 2025 - Bluefield Daily Telegraph
ResMed Inc. (NYSE:RMD) Stake Increased by NEOS Investment Management LLC - MarketBeat
Jim Cramer On ResMed Inc. (RMD) – “I’m With Mick! ResMed’s Doing Quite Well” - Insider Monkey
ResMed Inc. (NYSE:RMD) is a favorite amongst institutional investors who own 72% - simplywall.st
Solid sales from ASX healthcare leader - Morningstar.com.au
Is ResMed Stock Outperforming the Dow? - Nasdaq
ResMed initiated with an Overweight at Morgan Stanley - Yahoo Finance
Is ResMed Stock Outperforming The Dow? - Barchart
Resmed Says CPAP Therapy Reduces Risk Of Death By 37% In Sleep Apnea Patients - Nasdaq
Resmed’s Brand Evolution - Sleep Review
Aviso Financial Inc. Purchases 5,310 Shares of ResMed Inc. (NYSE:RMD) - MarketBeat
Why ResMed (RMD) is a Top Growth Stock for the Long-Term - Yahoo Finance
Why Breville, Flight Centre, Orica, and ResMed shares are dropping today - MSN
The Zacks Analyst Blog Highlights NVIDIA, Resmed, GE HealthCare And Medtronic - Barchart
The Zacks Analyst Blog Highlights NVIDIA, Resmed, GE HealthCare and Medtronic - Yahoo Finance
Why APA, Aurelia Metals, Magnetic Resources, and ResMed shares are rising today - MSN
ResMed’s chief commercial officer sells $2.33 million in stock By Investing.com - Investing.com Australia
United States Sleep Apnea Devices Market Research and - GlobeNewswire
RMD Stock Likely to Benefit From the New Brand Evolution Strategy - Yahoo Finance
Should you buy this top ASX share in the dip? - MSN
Resmed to Consolidate Portfolio into One Brand; Shares Fall 5% -March 12, 2025 at 12:33 am EDT - Marketscreener.com
ResMed CFO Executes Stock Sale Under Rule 10b5-1 Plan - TipRanks
ResMed CFO Brett Sandercock sells $230,360 in company stock By Investing.com - Investing.com South Africa
ResMed CFO Brett Sandercock sells $230,360 in company stock - Investing.com India
Resmed Chief Commercial Officer Offloads $2.3 Million Worth of Shares -March 11, 2025 at 06:27 pm EDT - Marketscreener.com
Resmed Inc Announces Proposed Sale of Securities - TipRanks
ResMed Inc. CEO Reports Stock Transactions Under Rule 10b5-1 Plan - TipRanks
ResMed’s chief commercial officer sells $2.33 million in stock - Investing.com
Resmed unveils unified brand to streamline services - MassDevice
ResMed CEO Michael J. Farrell sells $1.84 million in stock - Investing.com India
Resmed Unveils Unified Brand To Lead The Global Sleep And Health Technology Revolution - Marketscreener.com
Resmed Unveils Unified Brand to Lead the Global Sleep and Health Technology Revolution - The Korea Bizwire
Resmed Consolidating Brands, Product Lines Under Single Name -March 11, 2025 at 09:25 am EDT - Marketscreener.com
Resmed Unveils Comprehensive Brand Evolution to Enhance Global Sleep and Breathing Health Engagement - Nasdaq
Respiratory Inhalers Market to Witness Remarkable Growth with ResMed Inc., Fisher & Paykel Healthcare, Medtronic - openPR
7.08%
자본화:
|
볼륨(24시간):